MedCity FemFwd: How Women’s Health Advocates Is Pushing for Change
In this episode, we’re joined by Liz Powell, founder of Women's Health Advocates. We discussed the organization’s policy priorities in the women's health space.
FamilyWell Health Lands $8M to Grow Women’s Mental Health Support
FamilyWell's financing was led by New Markets Venture Partners and included participation from .406 Ventures, GreyMatter Capital, The Alix Foundation, The Donna Fund and The Lee Foundation.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
Why the Women’s Health Space Needs to Expand Beyond Reproductive Health
Health tech company Visana is urging the women’s health industry to expand its focus beyond reproductive care to address broader issues like cardiometabolic health, obesity and hormonal conditions that affect the majority of women outside the family-building years.
Bayer Menopause Drug Lands FDA Approval, Bringing Competition to an Astellas Product
Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to temperature regulation. The once-daily pill came from Bayer’s 2020 acquisition of KaNDy Therapeutics.
Visana Health Secures $24M for Women’s Health Clinic
Visana Health's Series A round was led by Noro-Moseley Partners and included participation from The Cigna Group Ventures, Intermountain Ventures, Flare Capital Partners and Frist Cressey Ventures.
MedCity FemFwd: How Evvy Is Advancing Women’s Health Research
In this episode, we’re joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women’s health research and what she hopes to achieve as a founding member of the Milken Institute’s Women’s Health Network.
presented by
Could QuantalX’s Device Make Managing Brain Health Easier?
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.
Pharmacogenomics Can Help Buffer Female Cardiac Patients From Impacts Of Funding Cuts
Pharmacogenomics offers an opportunity to help shield female cardiology patients from some of the negative impacts by helping to streamline the process from diagnosis to finding a successful treatment for that patient.
MedCity FemFwd: Designing Healthcare Spaces for Women
In this episode, we’re joined by Abbie Clary, executive director of Health for All for CannonDesign, an architecture design company. She discusses why healthcare traditionally hasn’t been built around women, and what needs to change.
MedCity FemFwd: Advancing Value-Based Care in Women’s Health
In this episode, we’re joined by Dr. Keith Berkle, chair of the Privia Medical Group — Mid-Atlantic Board of Governors and president of Virginia Women’s Center, who discusses the challenges OBGYNs face in transitioning to value-based care.
Talkspace, Tia Health Launch Women’s Mental Health Partnership
Through a new partnership, Tia Health’s primary care providers can now refer women in need of mental health support to Talkspace, where they can access therapy and psychiatric services.
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Atherosclerosis and Osteoporosis: A Tale of Two Conditions
Why has there been so little progress against the rate of osteoporotic fractures and the associated morbidity and mortality? The deaths are real, the pain and suffering are real — and almost all of us have witnessed it. And, of course, the cost to our health system, $57 billion per year, is real.
Using Case Management to Improve Maternal Health Outcomes
A new report from ProgenyHealth highlights the importance of taking a multipronged approach to identifying and managing risk factors for maternal health and taking steps to reduce the risks of premature births.
Women’s Health Company Tia Health Launches Longevity Service Line
Tia Health recently launched its longevity service line, which is starting with a focus on heart health. It includes labs and one-on-one provider guidance.
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test
Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma.
MedCity FemFwd: Inside Springboard Enterprises and Accenture’s New Women’s Health Report
In this episode, we’re joined by Julia Lasater, management consulting senior analyst at Accenture, and Amani Bright, senior program manager at Springboard Enterprises. They discuss the key takeaways of their recent women's health report.